Related Experiment Videos
Altered phosphatase activity in heart failure, influence on Ca2+ movement
1Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, Domagkstr. 12, 48149 Münster, Germany.
Abstract:
Many cardiac proteins undergo reversible phosphorylation. While the protein kinases which bring about phosphorylations are well studied, less effort has been put into the dephosphorylating phosphatases (for an earlier review compare 14). An important event in the heart, which is controlled by phosphorylation, is the uptake of Ca2+ by the sarcoplasmic reticulum (SR). This process is brought about by a SR Ca2+ ATPase (SERCA) and accounts for relaxation. The amount of Ca2+ pumped by SERCA is enhanced when phospholamban (PLB), an intrinsic protein of the SR, is phosphorylated and is diminished when PLB is dephosphorylated. PLB is dephosphorylated by protein phosphatases (PPs) like PP1. As the activity of PP1 is enhanced in heart failure, subsequent dephosphorylation by of, e.g., PLB may explain the impaired relaxation of the human heart. Thus, PPs may play an important role in the etiology and/or symptoms of heart failure.
Insights
Protein phosphatases (PPs) dephosphorylate cardiac proteins like phospholamban (PLB), impacting heart relaxation. Enhanced PP1 activity in heart failure may impair relaxation by dephosphorylating PLB.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Cardiac protein phosphorylation regulates key functions, including calcium (Ca2+) uptake by the sarcoplasmic reticulum (SR).
- Protein kinases are well-studied, but the role of dephosphorylating phosphatases (PPs) in cardiac function remains less explored.
- Phospholamban (PLB), an SR protein, modulates SR Ca2+ ATPase (SERCA) activity; its phosphorylation enhances Ca2+ pumping, crucial for heart relaxation.
Purpose of the Study:
- To investigate the role of protein phosphatases (PPs) in cardiac function, particularly in relation to phospholamban (PLB) dephosphorylation.
- To explore the potential contribution of PPs to the impaired relaxation observed in heart failure.
Main Methods:
- The study focuses on the dephosphorylation of phospholamban (PLB) by protein phosphatases (PPs), specifically protein phosphatase 1 (PP1).
- The research examines the activity of PP1 in the context of heart failure and its effect on PLB dephosphorylation.
Main Results:
- Phospholamban (PLB) dephosphorylation by protein phosphatases (PPs) diminishes the activity of the SR Ca2+ ATPase (SERCA).
- Protein phosphatase 1 (PP1) activity is found to be enhanced in heart failure.
- Enhanced PP1 activity leads to increased dephosphorylation of PLB, potentially impairing cardiac relaxation.
Conclusions:
- Protein phosphatases (PPs), particularly PP1, play a significant role in regulating cardiac relaxation through the dephosphorylation of phospholamban (PLB).
- Elevated PP1 activity in heart failure may contribute to impaired myocardial relaxation, suggesting PPs are involved in the etiology or symptoms of heart failure.